Evidence map›Paper›PMID 36277440›Full record

ArticleSAGE open medicine2022

Determining laboratory parameters in pregnant women with severe COVID-19.

Suskhan Djusad, Rima Irwinda, Achmad Kemal Harzif, Raymond Surya, Noroyono Wibowo, Yudianto Budi Saroyo, Jm Seno Adjie

Open access · goldAbstract read
In one paragraph

Article in SAGE open medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Suskhan DjusadDepartment of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta/Faculty of Medicine, Universitas Indonesia, Indonesia.
Rima IrwindaDepartment of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta/Faculty of Medicine, Universitas Indonesia, Indonesia.ORCID https://orcid.org/0000-0002-6260-6273
Achmad Kemal HarzifDepartment of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta/Faculty of Medicine, Universitas Indonesia, Indonesia.
Raymond SuryaDepartment of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta/Faculty of Medicine, Universitas Indonesia, Indonesia.ORCID https://orcid.org/0000-0001-5119-0674
Noroyono WibowoDepartment of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta/Faculty of Medicine, Universitas Indonesia, Indonesia.
Yudianto Budi SaroyoDepartment of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta/Faculty of Medicine, Universitas Indonesia, Indonesia.
Jm Seno AdjieDepartment of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital, Jakarta/Faculty of Medicine, Universitas Indonesia, Indonesia.
University of Indonesia · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Coronavirus disease causes a wide spectrum of clinical picture in pregnant women. There are still a few studies concerning laboratory parameters to differentiate the severity of coronavirus disease-19 in pregnant patients. This article aims to identify the cut-off on laboratory parameters between pregnant women with asymptomatic/mild/moderate and severe/critical coronavirus disease-19 illness. Methods: All coronavirus disease-19 pregnant women coming to Dr. Cipto Mangunkusumo hospital between January and August 2021 were recruited into this cross-sectional study. All data extracted from medical records were classified into demographic characteristics and laboratory parameters. We defined demographic characteristics as age, parity, systolic, and diastolic blood pressure, heart rate, temperature, respiratory rate, and oxygen saturation. Laboratory parameters measured in this study consisted of complete blood count, renal function test including urea, creatinine, liver function test including aspartate transferase, alanine transferase, infection marker test including procalcitonin, C-reactive protein, interleukin-6, cycle threshold values, ferritin, coagulation test including d-dimer, fibrinogen, random blood glucose, albumin, electrolytes. Data analysis was performed using SPSS statistics. Results: There were 159 cases assessed in this study consisting of 130 (81.8%) patients with asymptomatic/mild/moderate illness and 29 (18.2%) patients with severe/critical illness of coronavirus disease-19. Of 28 laboratory parameters, 12 of them were significant statistically; thus, it resulted to make a cut-off using receiver operating characteristic curve and show relative risk, and 95% confidence interval. In multivariate analysis that aspartate transferase, D-dimer, and albumin were laboratory parameters impacted to the severity of coronavirus disease-19 in pregnant women. The area under receiver operating characteristic curve was 0.834 (95% CI 0.736-0.932). Conclusion: Of all laboratory parameters, urea, aspartate transferase, alanine transferase, procalcitonin, C-reactive protein, lactate dehydrogenase (LDH), ferritin, D-dimer, random blood glucose, cycle threshold values, albumin, and chloride differs between asymptomatic/mild/moderate, and severe/critical illness coronavirus disease-19 in pregnant women; aspartate transferase, D-dimer, and albumin were laboratory parameters impacted the most to the severity of coronavirus disease-19 in pregnant women.

Indexed as

COVID-19laboratory parameterspregnant women

Identifiers

PMID36277440
PMCPMC9579820
OpenAlexW4307234681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.